Novocure Ltd (NASDAQ:NVCR)
| 202.27 Delayed Data As of 3:59pm ET |  +5.01 / +2.54%Today’s Change | 55.40 Today|||52-Week Range 220.48 | +16.89% Year-to-Date |
Latest NVCR News | Press Releases
| Is Novocure Stock Overvalued? Apr 30 / MotleyFool.com - Paid Partner Content | NovoCure (NVCR) is Overbought: Is A Drop Coming? Apr 26 / Zacks.com - Paid Partner Content |
| NovoCure (NVCR) Q1 2021 Earnings Call Transcript Apr 29 / MotleyFool.com - Paid Partner Content | Analysts Estimate NovoCure (NVCR) to Report a Decline in Earnings: What to Look Out for Apr 22 / Zacks.com - Paid Partner Content |
| Why NovoCure (NVCR) Might Surprise This Earnings Season Apr 28 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 197.26 |
| Today’s open | 200.04 |
| Day’s range | 196.00 - 205.80 |
| Volume | 41,470 |
| Average volume (3 months) | 943,694 |
| Market cap | $21.1B |
Data as of 3:59pm ET, 05/05/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +40.72% |
| P/E ratio | 2,022.7 |
| Price/Sales | 38.11 |
| Price/Book | 43.84 |
Competitors
Data as of 4:00pm ET, 05/05/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $494.4M |
| Annual profit (last year) | $19.8M |
| Net profit margin | 4.01% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters St. Helier, Jersey |
Forecasts
